Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic contains semaglutide, a synthetic version of GLP-1, a hormone your gut naturally produces after eating. When semaglutide enters your bloodstream, it signals your brain that you are full longer, slows stomach emptying, and reduces cravings—triggering measurable weight loss in clinical trials. Understanding this mechanism helps explain why this drug became one of the most prescribed weight-loss treatments in recent years.
How Semaglutide Works to Trigger Weight Loss
Semaglutide binds to GLP-1 receptors throughout your digestive system and brain. Once activated, these receptors send signals that increase feelings of fullness after smaller meals, delay how fast your stomach empties food into the intestines, and lower your appetite set point. This triple action—satiety, slower digestion, and reduced hunger—creates a caloric deficit without requiring extreme willpower or starvation diets.
Clinical trials published in peer-reviewed journals show that participants taking semaglutide lost 15–22% of their body weight over 68 weeks, compared to 2–3% in placebo groups. The weight loss occurs gradually as your body adjusts to eating less and feeling satisfied sooner. Most patients see meaningful results within 4–8 weeks, though individual responses vary based on genetics, lifestyle, and baseline metabolism.
Semaglutide vs. Other GLP-1 Medications: Key Differences
Semaglutide is a GLP-1 receptor agonist, meaning it mimics only one hormone pathway. Tirzepatide, a newer alternative, is a GLP-1 and GIP receptor agonist—it targets two pathways simultaneously. Because tirzepatide engages two receptors, clinical data suggests it may produce slightly more weight loss (up to 22% in trials) and greater improvements in blood sugar control. Both medications are available at PlexusDx in injection and oral forms.
Semaglutide injections are administered once weekly, while oral semaglutide is taken daily. Injection forms typically produce faster, more consistent results because they bypass stomach acid and absorption variability. PlexusDx offers compounded semaglutide injections starting at $149 per month—your dose may need to go up, but your price won't.
Why Your Genetic Profile Matters for Semaglutide Response
Not everyone responds to semaglutide equally. Variations in the GLP1R gene (rs6923761) and the GIPR gene (rs1800437) influence how strongly your cells respond to the medication and how much weight you're likely to lose. The FTO gene (rs9939609) and MC4R gene (rs17782313) affect your baseline appetite regulation and metabolism rate. These genetic differences explain why one patient loses 30 pounds while another loses 10 pounds on the same dose.
PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights to predict your individual response to semaglutide and tirzepatide before you start treatment. This $99 add-on test (available after your first month) helps optimize your medication choice and expected outcomes. Patients who know their genetic profile often achieve faster weight loss and fewer medication adjustments.
Getting Compounded Semaglutide: Cost, Access, and Safety
PlexusDx provides semaglutide compounded by licensed 503A pharmacies—the highest safety standard for custom medications. Unlike Ozempic (brand-name), compounded semaglutide is not FDA-approved but is formulated under strict pharmacy regulations and quality oversight. PlexusDx serves all 50 states, requires no insurance, and charges a flat $149 per month for semaglutide injections regardless of dose level. Your dose may need to increase as your body adjusts, but your monthly cost remains constant.
Semaglutide injections are HSA and FSA eligible, reducing your true out-of-pocket cost. PlexusDx sends pre-filled pens or vials to your home with detailed injection instructions and 24/7 patient support. Common side effects—nausea, constipation, reduced appetite—typically fade within 2–4 weeks as your body adapts. Serious adverse events are rare when prescribed appropriately, though people with personal or family thyroid cancer history should discuss semaglutide with their provider first.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is semaglutide the same ingredient in Ozempic and Wegovy?
Yes. Ozempic and Wegovy both contain semaglutide manufactured by Novo Nordisk. The difference is indication: Ozempic is labeled for type 2 diabetes, while Wegovy is labeled for weight management. PlexusDx offers compounded semaglutide with identical active ingredient for weight loss at a lower cost.
How does semaglutide reduce hunger compared to diet alone?
Semaglutide chemically signals your brain's satiety centers and slows gastric emptying, creating sustained fullness. Dieting alone relies on willpower; semaglutide rewires appetite regulation at the neurological level. Clinical trials show semaglutide-treated patients eat 300–500 fewer calories daily without conscious restriction.
Can I get compounded semaglutide without a prescription?
No. PlexusDx requires a valid prescription from a licensed provider. You can consult with an online provider through PlexusDx's partner network, or use your existing provider's prescription. All medications are compounded by licensed 503A pharmacies and shipped directly to your home.
What are the most common side effects of semaglutide?
Nausea, constipation, reduced appetite, and mild stomach discomfort occur in 20–40% of users during the first 4 weeks. These effects usually resolve as your body adjusts. Serious side effects (pancreatitis, thyroid cancer) are rare. Always disclose your medical history and current medications to your provider before starting semaglutide.
How does the Precision Peptide Genetic Test help predict my semaglutide success?
PlexusDx's genetic test identifies your GLP1R, GIPR, FTO, and MC4R variants—genes that directly control how your body responds to semaglutide. If your genetic profile shows strong GLP-1 sensitivity, you're more likely to lose 20%+ of body weight; if sensitivity is lower, tirzepatide may be a better option. The test costs $99 and is available after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where Does Ozempic Get Injected? Understanding Injection Techniques for Effective Weight Loss
Is Feeling Cold a Side Effect of Mounjaro?